Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming-Reference-Cited by-同舟云学术

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming

Published:2020-05-13 Issue: Volume:11 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Villalba Adrian,Rodriguez-Fernandez Silvia,Perna-Barrull David,Ampudia Rosa-Maria,Gomez-Muñoz Laia,Pujol-Autonell Irma,Aguilera Eva,Coma Mireia,Cano-Sarabia Mary,Vázquez Federico,Verdaguer Joan,Vives-Pi Marta

Funder

Fundació la Marató de TV3

Agència de Gestió d'Ajuts Universitaris i de Recerca

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference51 articles.

1. β cells can be generated from endogenous progenitors in injured adult mouse pancreas;Xu;Cell,2008

2. Artemisinins target GABA A receptor signaling and impair α cell identity;Li;Cell,2017

3. Long-term GABA administration induces alpha cell-mediated βeta like cell neogenesis;Ben-othman;Cell,2017

4. Evidence of unrestrained beta-cell proliferation and neogenesis in a patient with hyperinsulinemic hypoglycaemia after gastric bypass surgery;Dadheech;Islets,2018

5. A review of network-based approaches to drug repositioning;Lotfi Shahreza;Brief Bioinform,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges;Drugs;2023-12-21

2. Berberine enhances the function of db/db mice islet β cell through GLP-1/GLP-1R/PKA signaling pathway in intestinal L cell and islet α cell;Frontiers in Pharmacology;2023-07-04

3. Unveiling chronic spontaneous urticaria pathophysiology through systems biology;Journal of Allergy and Clinical Immunology;2023-04

4. Type-2 Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor toward Predicting Possible Association;Computational Molecular Bioscience;2023

5. New targets for old drugs;New Horizons in Natural Compound Research;2023